Company Overview and News

 
Bursa Malaysia continues uptrend at mid-morning

2017-11-17 themalaymailonline
At 11.05am, the benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) stood at 1,720.48, up 2.37 points from Thursday’s close of 1,718.11, after opening 2.70 points better at 1,720.81. — Reuters picKUALA LUMPUR, Nov 17 ― Bursa Malaysia continued its uptrend at mid-morning today, supported by gains in blue-chips led by Genting Bhd and Axiata.
Upvote Downvote

 
Bursa rebounds to be marginally higher at mid-morning

2017-11-16 themalaymailonline
KUALA LUMPUR, Nov 16 — Bursa Malaysia rebounded to trade slightly higher at mid-morning today, lifted by buying support in selected heavyweights led by Petronas-linked companies.
Upvote Downvote

 
Bursa Malaysia falls on selling in heavyweights

2017-11-15 themalaymailonline
KUALA LUMPUR, Nov 15 — Bursa Malaysia slipped to its lowest level since March 15, 2017 to finish at an intra-day low today on continued selling pressure in heavyweights amid weaker crude oil prices.
Upvote Downvote

 
Bursa shares slip into red at mid-morning

2017-11-15 themalaymailonline
At 11am, the benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) stood at 1,731.09, down 2.52 points from yesterday’s close of 1,733.61. — Bernama picKUALA LUMPUR, Nov 15 ― Share prices on Bursa Malaysia slipped into the red at mid-morning today, weighed on by selling activities in selected heavyweights led by Maybank and Maxis.
Upvote Downvote

 
KL shares lower at mid-day

2017-11-14 themalaymailonline
KUALA LUMPUR, Nov 14 — Bursa Malaysia turned lower at the end of the morning session today as the market succumbed to selling pressure especially in selected heavyweights led by Genting Bhd and PetGas.
Upvote Downvote

 
KL shares mixed at mid-morning

2017-11-14 themalaymailonline
The benchmark index opened 5.78 points higher at 1,743.27. — Malay Mail picKUALA LUMPUR, Nov 14 — Share prices on Bursa Malaysia were traded mixed at mid-morning as gains in heavyweights led by Maybank provided some support to the key index.
Upvote Downvote

 
MISC leads gains on KLCI

2017-11-06 thestar.com.my
KUALA LUMPUR: The local bourse bucked the trend in the morning session amid reports that  foreign selling in the previous week on the local equity market had slowed to its lowest level so far this year. According to MIDF research, a "feel good vibe" had contributed to net foreign buying of RM133.4mil last Monday when the market reopened after the announcement of Budget 2018. Key Asian markets, however, were a sea of red on Monday as they tumbled from decade-highs in the lead up to US President Donald Trump's meetings with his Chinese and Russian counterparts on his Asian tour.
Upvote Downvote

 
Heitech, LCTH, PMB, Glomac, Maybulk, TSR, GHL, Sanbumi, Brite-Tech, Master-Pack, Berjaya Assets, Permaju, Ire-Tex, MESB, Mudajaya, Tower, Ge-Shen, Key Allianc

2017-04-05 theedgemarkets
KUALA LUMPUR (April 5): theedgemarkets.com highlighted 18 stocks with momentum at Bursa Malaysia's afternoon market close today. Two stocks showed positive momentum while 16 had negative momentum.   Stocks with positive momentum were :   Heitech Padu Bhd – up 8.5 sen at 94.5 sen   LCTH Corp Bhd – up 3.5 sen at 61 sen
Upvote Downvote

 
KLCI gets off to flat start in line with region

2016-11-17 theedgemarkets
KUALA LUMPUR (Nov 17): The FBM KLCI got off to a flat start today, in line with the slip at most regional markets.
Upvote Downvote

 
Bursa Malaysia opens higher

2016-10-06 themalaymailonline
At 9.10am, the benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) rose 1.55 points to 1,664.47 against yesterday’s close of 1,662.92. — Reuters picKUALA LUMPUR, Oct 6 — Bursa Malaysia opened higher this morning supported by selected heavyweights led by TNB, on the back of encouraging economic data from the United States, dealers said.
Upvote Downvote

 
KLCI edges up in line with firmer regional markets

2016-10-06 theedgemarkets
KUALA LUMPUR (Oct 6): The FBM KLCI edged up in early trade this morning in line with the firmer regional markets, lifted by select blue chips.
Upvote Downvote

 
KLCI could ease from recent highs on profit taking

2016-08-16 theedgemarkets
KUALA LUMPUR (Aug 17): The FBM KLCI could ease from recent highs on profit taking in line with the overnight weaker close at Wall Street and other global markets.
Upvote Downvote

 
Box-Pak, Press Metal, PMB Technology, DNex, TAHPS Group, MMS Ventures, MHB, White Horse, Marco Holdings, CCM, V.S. Industry and Maybank

2016-08-16 theedgemarkets
KUALA LUMPUR (Aug 16): Based on corporate announcements and news flow today, companies that might be in focus tomorrow (Wednesday, Aug 17) include: Box-Pak (Malaysia), Press Metal, PMB Technology, Dagang NeXchange (DNex), TAHPS Group, MMS Ventures, Malaysia Marine and Heavy Engineering Holdings (MHB), White Horse, Marco Holdings, Chemical Company of Malaysia (CCM), V.S. Industry and Malayan Banking (Maybank).
Upvote Downvote

 
K-Star, Pos Malaysia, Aemulus, George Kent, Nestle, PMB Technology

2016-08-04 theedgemarkets
KUALA LUMPUR (Aug 4): theedgemarkets.com has highlighted six stocks with momentum at the midday market close today. Two of the stocks showed positive momentum, while four showed negative momentum.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...